$TSUNAMI WAVE

[AliAngel]

NSAV Info link; Net Savings Link, Inc. NSAV Board









Net Savings Link, Inc. NSAV Board
Company Name: Net Savings Link Inc., Stock Symbol: NSAV, Last Post Date: 8/10/2014 1:49:48 PM, Total Posts: 35732, Industry Type: Internet - E-Commerce
View on investorshub.advfn.com
Preview by Yahoo


Million Penny March | Penny Stock Picks









Million Penny March | Penny Stock Picks
Beating the penny stock market one chart at a time & earning members the freedom that comes with a million penny/month trading income! MPM Penny Stock Picks.
View on www.millionpennymarch...
Preview by Yahoo


CURRENTLY UNDER CONSTRUCTION

Net Savings Link, Inc. (OTC: Pink: NSAV) (PINKSHEETS: NSAV)




The research below explains who this company was and were they are going:

NetSavingsLink.com


The Company; Net Savings Link was acquired from the previous directors on June 18 2014
by a successful New York business man; Steven Baritz:

ITEM 1.01 ENTRY INTO A MATERIALLY DEFINITIVE AGREEMENT.

On about June 18, 2014, we entered into an agreement with Global Distribution Inc. a New York corporation ("GDI"); David Saltrelli and Peter Schuster, holders of all of the issued and outstanding shares of our Series A preferred stock; and, Steven Baritz, the sole shareholder of GDI, wherein Steven Baritz acquired all of the issued and outstanding shares of our Series A preferred stock (1,500,000 shares) from David Saltrelli and Peter Schuster in exchange for Baritz transferring all of the issued and outstanding shares of common stock of GDI to us. Each share of Series A preferred stock has 1,000 votes. Upon completion of the aforementioned transaction, David Saltrelli and Peter Schuster, will continue to own 7,200,000 shares of our common stock and in the event of any action which causes a reduction in said shares, we will issue additional shares of common stock to David Saltrelli and Peter Schuster in order to maintain their ownership in 7,200,000 shares of our common stock. David Saltrelli and Peter Schuster have delivered the Series A preferred shares to Baritz and Baritz has delivered the shares of common stock of GDI to us and accordingly this agreement has terminated. Further, outstanding balances owed to our auditors, attorney, Asher Enterprises, and Pacific Stock Transfer will be paid within 24 hours of closing. As of the date hereof, said amounts have not been paid.


ITEM 2.01 COMPLETION OF ACQUISITION OR DISPOSITION OF ASSETS.

On about June 18, 2014, we entered into an agreement with Global Distribution Inc. a New York corporation ("GDI"); David Saltrelli and Peter Schuster, holders of all of the issued and outstanding shares of our Series A preferred stock; and, Steven Baritz, the sole shareholder of GDI, wherein Steven Baritz acquired all of the issued and outstanding shares of our Series A preferred stock (1,500,000 shares) from David Saltrelli and Peter Schuster in exchange for Baritz transferring all of the issued and outstanding shares of common stock of GDI to us. Each share of Series A preferred stock has 1,000 votes. Upon completion of the aforementioned transaction, David Saltrelli and Peter Schuster, will continue to own 7,200,000 shares of our common stock and in the event of any action which causes a reduction in said shares, we will issue additional shares of common stock to David Saltrelli and Peter Schuster in order to maintain their ownership in 7,200,000 shares of our common stock. David Saltrelli and Peter Schuster have delivered the Series A preferred shares to Baritz and Baritz has delivered the shares of common stock of GDI to us. Further, outstanding balances owed to our auditor, attorney, Asher Enterprises, and Pacific Stock Transfer will be paid within 24 hours of closing. As of the date hereof, said amounts have not been paid.


ITEM 5.01 CHANGES IN CONTROL OF REGISTRANT

On or about June 18, 2014, David Saltrelli and Peter Schuster, holders of all of the issued and outstanding shares of our Series A preferred stock (1,500,000 shares with each share having 1,000 votes) transferred said shares of Series A preferred stock to Steven Baritz. The aforementioned shares of Series A preferred stock represented approximately 66.18% of our voting power. The common shares and Series A preferred shares vote together on all matters submitted to our shareholders. Steven Baritz does not own any shares of our common stock.



November 1986 – June 2014
President/CEO Island Federal Mortgage, Ltd.
Hauppauge, N.Y. Company was privately held.

A residential and commercial mortgage firm based on Long Island, NY, that was licensed in NY, and FL. Arranged and structured residential and commercial mortgages, and maintained a correspondent channel with over 75 institutional and private secondary market entities. Harnessed strengths in forecasting and opportunity identification to effectively compete in the marketplace, and drive peak productivity from the sales and origination department.


Then to make sure Steven was in control for the shareholders, Steven had the old directors step down with a few shares:

ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS

On June 18, 2014, Steven Baritz was appointed to our board of directors and appointed president, principal executive officer, secretary, treasurer, principal financial officer, and principal accounting officer. Thereafter, David Saltrelli, Peter Schuster, and Jon Wallen resigned as officers and directors. We have not entered into any compensation arrangements with Mr. Baritz with respect to his employment with us.



Net Savings Link Announces the Acquisition of Global Distribution, a Healthcare Products Distribution Company


http://www.otcmarkets.com/stock/NSAV/news

CLEARWATER, FL, Jun 18, 2014 (Marketwired via COMTEX) -- Net Savings Link, Inc. (OTC Pink: NSAV) (PINKSHEETS: NSAV), today announced that the company has completed the acquisition of Global Distribution, Inc. Global Distribution is a distribution company that specializes in the distribution of health products to retail stores. Some of the types of products that the company distributes are supplements and vitamins, nutraceuticals, various natural remedies, and in places where it has been decriminalized, medical and recreational marijuana products as well.

Global's strength is that both the supplement/natural remedy, and marijuana product industries are currently very fractured, and local in nature. By offering manufacturers a distribution mechanism to seamlessly get their products into hundreds or thousands of dispensaries or retail establishments, the company is pre-positioned to service and fill a much-needed niche, and become the leader in an emerging industry.

www.globaldistributioncorp.net

NetSavingsLink.com

Future home of something quite cool.

If you're the site owner, log in to launch this site
If you are a visitor, check back soon.

Net Savings Link set out to isolate an opportunity in the market by filling a niche widely ignored, but with huge potential due to changing market conditions. The strategy is to have Net Savings Link file for a name change in the near future and change its overall business model along with its name to that of Global Distribution, Inc. In recognizing the tremendous opportunity in this emerging market, it only makes sense to focus on Global's business model. Global Distribution's CEO, Steven Baritz, will also be appointed to Net Savings Link's Board of directors, and eventually he will be appointed to the position of CEO to take over where previous management left off.
Mr. Baritz commented," I am extremely excited about becoming part of a publicly trading entity because it gives us the reach and access to capital we need to completely dominate this market, and to complete what we originally set out to do." There is no doubt that the Legal and Medicinal Marijuana industry is spreading and growing, and the natural remedy market is also growing in leaps and bounds, so being a company focused in those two previously fractured markets positions Net Savings Link to be a force to be reckoned with in the very near future.
The Distribution network is started for the first lines with this news release.
Steven Baritz, as a successful business man in New York, has the access and ties to the Finances as well as the right connections to get new products.
Global Distribution Inc is a registered business of New York state from the Secretary of State below:
NYS Department of State

Division of Corporations

Entity Information

The information contained in this database is current through July 31, 2014.
Selected Entity Name: GLOBAL DISTRIBUTION, INC.
Selected Entity Status Information
Current Entity Name: GLOBAL DISTRIBUTION, INC.
DOS ID #: 4571948
Initial DOS Filing Date: MAY 05, 2014
County: SUFFOLK
Jurisdiction: NEW YORK
Entity Type: DOMESTIC BUSINESS CORPORATION
Current Entity Status: ACTIVE

Selected Entity Address Information
DOS Process (Address to which DOS will mail process if accepted on behalf of the entity)
JUSTIN SINDELMAN
415 EAST MAIN STREET SUITE:1
PORT JEFFERSON, NEW YORK, 11777


The next steps that the new Baritz's team made, is too start adding there own lines of retail items with the introduction of:



"Nutra Horizon Nutraceuticals."

Net Savings Link Announces an Exclusive, International Product Licensing Agreement to Market, Distribute, and
Sell a New Healthcare Product Brand Under the Label of Nutra Horizon Nutraceuticals.

http://www.otcmarkets.com/stock/NSAV/news

Aug 07, 2014 (eTeligis.com via COMTEX) -- CLEARWATER, FL, United States, via ETELIGIS INC., 08/07/2014 - - Net Savings Link, Inc. (OTC: Pink: NSAV) (PINKSHEETS: NSAV) today announced that Global Distribution Corp, a recent acquisition of NSAV, has formally executed an Exclusive International Licensing Agreement with Oglethorpe LTD, one of the most established Naturopathic formulators and producers of wellness products in the New York Region. Oglethorpe maintains an active and updated list of testimonials from people who use their wellness products on a continual basis, and who have achieved observational results of improved or resolved physiological conditions from the various Oglethorpe products. The agreement provides Global Distribution with the International license to exclusively market, distribute, and sell the proprietary healthcare products formulated by Oglethorpe LTD under the new private label, "Nutra Horizon Nutraceuticals."

The first step is too include his great friends and noted colleague in his field of Naturopathic Formulations & Producer of Wellness products:

About Oglethorpe LTD.


Oglethorpe, Ltd. is a New York Domestic Business Corporation filed on October 2, 2006. The company's filing status is listed as Active and its File Number is 3419434.
The company's principal address is 46 Mt Grey Road Setauket, New York 11733 and its mailing address is 46 Mt Grey Road Setauket, New York 11733.

The company has 1 principal on record. The principal is Fred Eichhorn from Setauket New York.

Oglethorpe, Ltd. is an Arizona Business filed on July 25, 2013. The company's File Number is listed as F18627514.

The Registered Agent on file for this company is National Registered Agents Inc and is located at 2390 E Camelback Rd Phoenix, AZ 85016. The company's principal address is Glendale Airpark Busines Centr 7225 N 110th Ave #6 Glendale, AZ 85307.

The company has 2 principals on record. The principals are Fred Eichhorn from Setauket NY and Lora Eichhorn from Setauket NY.
Oglethorpe Ltd, has been an emerging leader in the wellness and nutraceuticals marketplace for over 8 years, and distributes its products both domestically in the United States and internationally. Oglethorpe formulates, manufactures, and markets several proprietary wellness supplement products that have resulted in significant observational results in people with a diverse variety of illnesses, including Neuropathy, diabetes, most types of cancers, etc. The founder was a medical student, who is now a Naturopathic Doctor that graduated with a perfect 4.0 grade point average, and who was clinically diagnosed with advanced pancreatic cancer 38 years ago, and was given a prognosis of only 3-6 months to live after his surgery at the time. After his surgery, he consequently designed his own treatment protocol which included the compounds that are now featured in Oglethorpe's products, and he has been cancer free and in good health since that time. Annual sales of Oglethorpe have been increasing by nearly 50% year over year for the past 7 years, and they are constantly refining their products and branding themselves as an emerging leader in the mineral/nutraceuticals/wellness field as a consequence of the high success rate of positive observational results from the consumers of its various products.

Why Oglethorpe LTD.?
How will Dr. Eichhorn enhance the company
& the shareholders equity ahead:

http://www.fredeichhorn.com/home.html

http://cancercompassalternateroute.com/therapies/cellect/


Fred Eichhorn News 12 Cellect feature

https://www.youtube.com/watch?v=Psbw-EAmW8U


http://checkmedaily.com/health-beauty/diagnosed-no-evidence-of-cancer-treatment/



Diagnosed as No Evidence of Cancer after Treatment with Cellect



12011605001"" rel="nofollow" target="_blank">http://checkmedaily.com/health-beauty/diagnosed-no-evidence-of-cancer-treatment/";; rel="nofollow">
Diagnosed as No Evidence of Cancer after Treatment with Cellect. Below is a Collection of Testimonials as told by Fred Eichhorn, President of the National Cancer Research Foundation located in Port Jefferson Station, New York. National Cancer Research Foundation. NCRF is a Federally Registered 501(c)(3) & State ST-119.1 Not-For-Profit Corporation. For over a decade NCRF has been helping cancer patients return to a diagnosis of no evidence of cancer.
Also Please See Comments posted on www.Melanoma.org forum at the following links:

Amazing Story of Healing Terminal Cancer With Cellect

Anyone Heard of Cellect

More Success Stories with Cellect


http://cancercompassalternateroute.com/therapies/cellect/




http://www.melanoma.org/find-support/patient-community/mpip-melanoma-patients-information-page/cellect




Home
Products
Order
Information
Supplemental Facts
Articles
Recipes
Health Tips
Contact Us

http://cellect.org/products.php

The University of Mary Washington researched the efficacy of CELLECT™ in brain tissue and inflammation relative to Alzheimer's Disease and published their findings with the Virginia Academy of Sciences.
A PDF document can be found on the Virginia Academy of Science page. The article is located on page 24 of the PDF document (labeled page 26).
The information presented here is from this document. All formatting and emphasis are done to make reading easier and to highlight important points.
They did the research using mice. After 7 months, the inflammation reduced tremendously and the toxicity was basically non-existent.
Their experiment found that CELLECT™ showed over Eleven Million percent improvement (11,100,000 %).
These findings may also relate to other brain related biochemistry and physiological effects in the body as well.
PROCEEDINGS
ABSTRACTS OF PAPERS, 84th Annual Meeting of the Virginia Academy of Science
May 25-26, 2006,
Virginia Polytechnic Institute and State University, Blacksburg, VA
THE EFFECT OF ANTIOXIDANT VITAMINS AND NSAID DRUGS
ON PLAQUE FORMATION IN ALZHEIMER'S DISEASE.
Kristen M. Zach & Deborah A. O'Dell. Dept. of Biological sciences, Univ. Mary Washington, Fredericksburg, VA. 22401.
Alzheimer's Disease (AD) is characterized by the deposition of neurofibrillary tangles (NFTs), neuritic plaques composed of ß- amyloid, the release of inflammatory molecules such as TNF-a", and severe lipid peroxidation. Although the exact mechanism responsible for causing this cascade of events is unclear, it is clear that they are interrelated and act synergistically to cause neuronal death. Recent therapeutic strategies attempt to limit the neurotoxicitiy of oxidative and immune responses through the use of antioxidant vitamins and non-steroidal anti-inflammatory drugs (NSAIDs).
To determine the efficacy of Cellect brand vitamins and Ibuprofen in performing this role, we fed mice predisposed to plaque development (J10, JAX), rodent chow supplemented with either vitamins, Ibuprofen, or both for either 4 or 7 months. Mice from two litters were sacrificed and their brains removed and analyzed for presence of inflammation (TNF-a) and ß-amyloid protein. The level of TNF-a" in mice treated with supplements for 7 months was much lower than that of the control (0.046 ng/mg tissue vs 5113.38 ng/mg tissue, respectively). Analysis using light microscopy revealed that mice treated with a combination of Ibuprofen and vitamins for 7 months had the least amount of ß-amyloid protein in the brain. This study indicates that a long-term diet supplemented with both vitamins and NSAIDs may help prevent the onset of the hallmark pathologies associated with AD. This work was supported by an Undergraduate Research Grant from the University of Mary Washington.

Our Notes: Cellect effectiveness against neurotoxicity and immune responses reduced the plaque development.
After 7 months, the presence of inflammation was reduced from 5113.38 down to 0.046
5113.38/ 0.046 = 111,160.43 = 11,116,043 % improvement
Copyright © 1998-2014 Cellect Products

http://cellect.org/products.php

CELLECT™ is available in the following options

CELLECT™ Maxi-Blend Capsules
Contains the proprietary CELLECT™ blend in easy to swallow gelcaps. One serving is 24 capsules and each bottle contains 30 servings. A separate bottle of Cod Liver Oil gelcaps are included in each kit. Take 3 Cod Liver Oil gelcaps for each serving.

CELLECT™ Chocolate Flavor Powder Mix
Contains the proprietary CELLECT™ blend in a tasty flavored powder mix formula. One serving is 1 level scoop and each bottle contains 30 servings. A properly sized scoop is included in each bottle. A separate bottle of Cod Liver Oil gelcaps are included in each kit. Take 3 Cod Liver Oil gelcaps for each serving.

CELLECT™ Strawberry Flavor Powder Mix
Contains the proprietary CELLECT™ blend in a tasty flavored powder mix formula. One serving is 1 level scoop and each bottle contains 30 servings. A properly sized scoop is included in each bottle. A separate bottle of Cod Liver Oil gelcaps are included in each kit. Take 3 Cod Liver Oil gelcaps for each serving.

CELLECT™ Vanilla Flavor Powder Mix
Contains the proprietary CELLECT™ blend in a tasty flavored powder mix formula. One serving is 1 level scoop and each bottle contains 30 servings. A properly sized scoop is included in each bottle. A separate bottle of Cod Liver Oil gelcaps are included in each kit. Take 3 Cod Liver Oil gelcaps for each serving.

CELLECT™ Unflavored Powder Mix
Contains the proprietary CELLECT™ blend in a unflavored powder mix formula. One serving is 1 level scoop and each bottle contains 30 servings. A properly sized scoop is included in each bottle. A separate bottle of Cod Liver Oil gelcaps are included in each kit. Take 3 Cod Liver Oil gelcaps for each serving.
CELLECT™ Flavor Packets
Designed to be used with the CELLECT™ Unflavored Powder Mix. The Flavor Packets allow you to choose the strength of the flavoring by choosing how much, or how little of the flavoring to add. Flavor packets are only available with the purchase of a CELLECT™ Unflavored Powder Mix, and are provided at no additional cost. The following flavor packet options are available for use with the CELLECT™ Unflavored Powder Mix.
Chocolate
Vanilla
Strawberry
Mint Chocolate
Mom's Apple Pie





Corporate Information, News & Filings below:
http://www.otcmarkets.com/stock/NSAV/profile

Share Structure 8/01/2014

1 Billion AS
377,279,789 Outstanding
NSAV Security Details

Share Structure

Outside News Sources

Publish Date Headline
Aug 7, 2014 Net Savings Link Announces an Exclusive, International Product Licensing Agreement to Market, Distribute, and Sell a New Healthcare Product Brand Under the Label of "Nutra Horizon" Nutraceuticals
Aug 7, 2014 Net Savings Link Announces an Exclusive, International Product Licensing Agreement to Market, Distribute, and Sell a New Healthcare Product Brand Under the Label of Nutra Horizon Nutraceuticals.
Jul 23, 2014 Net Savings Link Announces the New Office Location of Global Distribution, at The National Cancer Research Foundation Facility
Jun 18, 2014 Net Savings Link Announces the Acquisition of Global Distribution, a Healthcare Products Distribution Company
SEC Filings

Form Type Received Period Ending Size Report
10-Q Jul 21, 2014 May 31, 2014 933.6 KB PDF RTF HTML XLS
NT 10-Q Jul 15, 2014 May 31, 2014 24.0 KB PDF RTF HTML
SC 13G Jun 24, 2014 42.1 KB PDF RTF HTML XLS
8-K Jun 23, 2014 Jun 20, 2014 42.6 KB PDF RTF HTML
10-Q/A Apr 22, 2014 Feb 28, 2014 137.9 KB PDF RTF HTML XLS
10-Q Apr 21, 2014 Feb 28, 2014 921.4 KB PDF RTF HTML XLS
NT 10-Q Apr 15, 2014 Feb 28, 2014 34.2 KB PDF RTF HTML
10-K Mar 17, 2014 Nov 30, 2013 1.7 MB PDF RTF HTML XLS
NT 10-K Feb 28, 2014 Feb 28, 2014 31.8 KB PDF RTF HTML
10-Q/A Jan 9, 2014 Aug 31, 2013 130.2 KB PDF RTF HTML XL